The Service of the Commission for the Protection of Competition has received a notification of a proposed concentration concerning the acquisition of part of the share capital of Avlogen Malta (Out-Licensing) Holding Ltd, by LetterOne Investment Holdings S.A. (Lux), via L1 Health GP S.a r.l..
L1 Health GP S. a r. l. is a limited liability company, duly registered under the laws of Luxembourg and is the holder of the L1 Health business unit of LetterOne Investment Holdings S. A. (Lux). LetterOne Investment Holdings S. A. (Lux) is a private investment holding company which targets investments mainly in the healthcare, telecommunications and technology sectors, and retail trade.
Avlogen Malta (Out-Licensing) Holding Ltd (hereinafter referred to as "Adalvo" or the "Target") is a company duly registered under the laws of Malta. Adalvo is a global pharmaceutical company and a provider of generic medicines and business-to-business biosimilars. This company does not have its own production facilities and all production is entrusted to various contracted production organizations and contracted, development and production organizations around the world. Adalvo enters into out-licensing agreements with business partners worldwide.